Summit Therapeutics, Inc. (SMMT)
17.55
+0.55
(+3.24%)
USD |
NASDAQ |
Sep 11, 16:00
17.90
+0.35
(+1.99%)
After-Hours: 16:50
Summit Therapeutics Gross Profit (TTM) : -0.174M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.174M |
| March 31, 2026 | -0.165M |
| December 31, 2025 | -0.146M |
| September 30, 2025 | -0.126M |
| June 30, 2025 | -0.104M |
| March 31, 2025 | -0.087M |
| December 31, 2024 | -0.089M |
| September 30, 2024 | -0.672M |
| June 30, 2024 | -1.251M |
| March 31, 2024 | -1.702M |
| December 31, 2023 | -2.05M |
| September 30, 2023 | -2.041M |
| June 30, 2023 | -1.442M |
| March 31, 2023 | -0.971M |
| December 31, 2022 | -0.596M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.281M |
| March 31, 2021 | -0.281M |
| December 31, 2020 | -0.281M |
| September 30, 2020 | -0.281M |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 2.130M |
| July 31, 2017 | 2.130M |
| April 30, 2017 | 2.109M |
| January 31, 2017 | 2.090M |
| October 31, 2016 | -0.0395M |
| July 31, 2016 | -0.0395M |
| April 30, 2016 | -0.0186M |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.5041M |
| July 31, 2015 | 0.5041M |
| April 30, 2015 | 0.5041M |
| January 31, 2015 | 0.5041M |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | -0.179M |
| Kezar Life Sciences, Inc. | -0.693M |
| Protara Therapeutics, Inc. | -0.343M |
| Clene, Inc. | -1.295M |